Aytu BioPharma has signed an agreement with Fabre-Kramer Pharmaceuticals to commercialise Exxua in the US market for MDD.

In this article, GlobalData examines key reimbursement trends that reflect the current delays to patient access across the ...

The EC has granted approval for a fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) plus venetoclax.

AI is revolutionizing the pharma supply chain by automating manual tasks, monitoring risks and providing predictive insights.

SCHOTT Pharma has announced an investment of €100m ($114m) to expand its manufacturing capacity for sterile RTU cartridges.

A study found no rise in ADHD cases, though some drugs for the disorder are still in shortage amid high demand.

The European Commission (EC) has granted marketing authorisation to Sydnexis for its low-dose atropine formulation SYD-101.

During an FDA panel discussion, the US health secretary prioritised easier routes to market for curative therapies.

China’s NMPA has approved Akeso's PD-1/CTLA-4 bispecific antibody, cadonilimab, to treat persistent, recurrent or metastatic ...

The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).

The alert comes amid some patients accessing GLP-1RAs through unregulated channels, where safety information is often not ...

Juvenescence has acquired Ro5 to enhance its AI/machine learning capabilities and improve research and development.